During the past decade, National Institute of Respiratory Diseases conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Institute of Respiratory Diseases" are "Chest Tube" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Pleural Diseases" (1 trials) and "Pneumothorax" (1 trials). Many other conditions were trialed in "National Institute of Respiratory Diseases" in a lesser frequency.

Most popular intervention types in "National Institute of Respiratory Diseases" are "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "BiPAP Pro 2, Phillips Respironics" (1 trials), "CPAP sham" (1 trials), "Clamping" (1 trials) and "Non Clampling" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Respiratory Diseases" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Institute of Respiratory Diseases". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Institute of Respiratory Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Respiratory Diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".